Bahareh Rasouli
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Capturing Pediatric Health and Medication Use in a US National Health Data Network.
Journal: Pharmacoepidemiology and drug safety
Published: April 23, 2025
Combining high quality data with rigorous methods: emulation of a target trial using electronic health records and a nested case-control design.
Journal: BMJ (Clinical research ed.)
Published: December 28, 2023
Does a prior diagnosis of infectious disease confer an increased risk of latent autoimmune diabetes in adults?
Journal: Diabetes/metabolism research and reviews
Published: August 29, 2023
A Meal Replacement Program for the Treatment of Obesity: A Cost-Effectiveness Analysis from the Swiss Payer's Perspective.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: December 23, 2020
A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
Journal: Journal of medical economics
Published: April 22, 2018
Coffee consumption, genetic susceptibility and risk of latent autoimmune diabetes in adults: A population-based case-control study.
Journal: Diabetes & metabolism
Published: February 23, 2018
Serious life events and the risk of latent autoimmune diabetes in adults (LADA) and Type 2 diabetes.
Serious life events and the risk of latent autoimmune diabetes in adults (LADA) and Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: June 15, 2017
Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA).
Journal: Diabetes & metabolism
Published: January 17, 2017
Use of Swedish smokeless tobacco (snus) and the risk of Type 2 diabetes and latent autoimmune diabetes of adulthood (LADA).
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: June 27, 2016
Last Updated: 09/26/2026